Advanced search
Publication Cover
OncoTargets and Therapy Volume 10, 2017 - Issue
Submit an article Journal homepage
55
Views
8
CrossRef citations to date
0
Altmetric
Review

Emerging treatments for HER2-positive early-stage breast cancer: focus on neratinib

Hampig Raphael Kourie1 Department of Oncology, Faculty of Medicine, Saint Joseph University, Beirut, Lebanon
,
Elie El Rassy1 Department of Oncology, Faculty of Medicine, Saint Joseph University, Beirut, Lebanon
,
Florian Clatot2 Department of Medical Oncology and IRON/U1245, Centre Henri Becquerel, Rouen, France;3 Breast Cancer Translational Research Laboratory
,
Evandro de Azambuja4 Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium
&
Matteo Lambertini3 Breast Cancer Translational Research Laboratory;4 Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, BelgiumCorrespondence[email protected]
Pages 3363-3372 | Published online: 10 Jul 2017

Citations (8)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (8)

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.